|
|
|
|
|
10.07.26 - 11:48
|
ABB Robotics collaborates with Roche to bring physical AI to laboratories (Cision)
|
|
|
Zurich, Switzerland, July 8, 2026
ABB Robotics collaborates with Roche to bring physical AI to laboratories
· Agreement lays the foundation for a new era of digitally connected labs enabled by intelligent robotics to provide significant efficiencies in laboratory workflows
· First applications under collaboration will support pathology slide handling and autonomous connectivity in Core Lab intralogistics
· Range of ABB Robotics' technologies deployed, including autonomous mobile manipulation and fixed articulating robots
ABB Robotics has announced a global collaboration...
|
|
|
|
|
|
|
|
|
09.07.26 - 07:03
|
Roche receives CE Mark for blood test to identify tuberculosis infection (GlobeNewswire EN)
|
|
|
Basel, 9 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings. The new solution enables fast, simple, and efficient diagnosis, and can provide results in under 24 hours. The Interferon Gamma Release Assay (IGRA) itself takes just 19 minutes per patient to process, which is approximately half the time of currently used methods. Laboratories now have an option for IGRA testing, with faster turnaround and scalable throughput on Roche's systems....
|
|
|
|
|
|
|
|
|
07.07.26 - 07:03
|
Roche presents new data in Alzheimer′s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC (GlobeNewswire EN)
|
|
|
Basel, 7 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it will present new data from its Alzheimer's disease portfolio at the Alzheimer's Association International Conference® 2026 (AAIC®) in London on 12-15 July. These data demonstrate how Roche is advancing the development of next-generation medicines and diagnostic tests, driven by a mission to slow, stop or even prevent the progression of Alzheimer's disease. In total, there are 18 oral and poster presentations. Highlights include five oral presentations as part of a trontinemab Featured Research Session, an oral Perspectives Session on neuroimmune targets such as NLRP3 for neurodegenerative diseases, and presentations on the use of Roche's Elecsys® pTau217 and pTau181 blood tests to support Alzheimer's disease diagnosis....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.07.26 - 10:48
|
European Champions: ASML, Novo und GSK sorgen für Schwung (Der Aktionaer)
|
|
|
In einer volatilen Börsenphase hat sich der European Champions Index sehr robust entwickelt und steht nun kurz vor einem neuen Allzeithoch. Wesentliche Erfolgsfaktoren sind die defensive Aufstellung und die Branchenstreuung. Mit Novo Nordisk, Novartis, Astrazeneca, GSK, Roche und Sanofi entfällt rund die Hälfte der Aktien auf den Gesundheitssektor....
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
